Review
doi: 10.1016/j.idc.2020.04.003.
Epub 2020 Sep 30.
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches
Affiliations
- PMID: 33011050
- DOI: 10.1016/j.idc.2020.04.003
Item in Clipboard
Review
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches
Infect Dis Clin North Am.
2020 Dec.
Abstract
Vancomycin and daptomycin are options for the initial treatment of patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. Treatment options for persistent MRSA bacteremia or bacteremia due to vancomycin-intermediate or vancomycin-resistant strains include daptomycin, ceftaroline, and combination therapies. There is a critical need for high-level evidence from clinical trials to allow optimally informed decisions in the treatment of MRSA bacteremia.
Keywords: Bacteremia; Ceftaroline; Daptomycin; Endocarditis; MRSA; Methicillin; Staphylococcus aureus; Vancomycin.
Copyright © 2020 Elsevier Inc. All rights reserved.
Similar articles
-
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.Infect Dis Clin North Am. 2016 Jun;30(2):491-507. doi: 10.1016/j.idc.2016.02.009. Infect Dis Clin North Am. 2016. PMID: 27208769 Review.
-
In vitro identification of underutilized β-lactam combinations against methicillin-resistant Staphylococcus aureus bacteremia isolates.Microbiol Spectr. 2024 Aug 6;12(8):e0097624. doi: 10.1128/spectrum.00976-24. Epub 2024 Jun 25. Microbiol Spectr. 2024. PMID: 38916355 Free PMC article.
-
Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia.J Antimicrob Chemother. 2015 Jan;70(1):311-3. doi: 10.1093/jac/dku322. Epub 2014 Aug 13. J Antimicrob Chemother. 2015. PMID: 25125677 No abstract available.
-
Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.Int J Infect Dis. 2017 Apr;57:27-31. doi: 10.1016/j.ijid.2017.01.019. Epub 2017 Jan 25. Int J Infect Dis. 2017. PMID: 28131729
-
Daptomycin and ceftaroline combination for the treatment of persistent methicillin-resistant Staphylococcus aureus bloodstream infections: a case series and literature review.J Chemother. 2024 Nov;36(7):540-545. doi: 10.1080/1120009X.2024.2340877. Epub 2024 Apr 12. J Chemother. 2024. PMID: 38606836 Review.
Cited by
-
Characteristics and calculations of paired vancomycin measurements for determination of 24-h area-under-curve (AUC).Pract Lab Med. 2023 Jan 28;34:e00310. doi: 10.1016/j.plabm.2023.e00310. eCollection 2023 Mar. Pract Lab Med. 2023. PMID: 36798591 Free PMC article.
-
Emerging Treatment Options for Acute Bacterial Skin and Skin Structure Infections and Bloodstream Infections Caused by Staphylococcus aureus: A Comprehensive Review of the Evidence.Infect Drug Resist. 2022 Apr 22;15:2137-2157. doi: 10.2147/IDR.S318322. eCollection 2022. Infect Drug Resist. 2022. PMID: 35498629 Free PMC article. Review.
-
The Resistance to Host Antimicrobial Peptides in Infections Caused by Daptomycin-Resistant Staphylococcus aureus.Antibiotics (Basel). 2021 Jan 20;10(2):96. doi: 10.3390/antibiotics10020096. Antibiotics (Basel). 2021. PMID: 33498191 Free PMC article.
-
Pre-surgical Nasal Decolonization of Staphylococcus aureus: A Health Technology Assessment.Ont Health Technol Assess Ser. 2022 Aug 23;22(4):1-165. eCollection 2022. Ont Health Technol Assess Ser. 2022. PMID: 36160757 Free PMC article. Review.
-
Vancomycin, Daptomycin, Antistaphylococcal β-Lactam, and Trimethoprim-Sulfamethoxazole Monotherapy and Combination Therapy in the Management of Methicillin-Resistant Staphylococcus aureus: A Network Meta-Analysis.Front Pharmacol. 2022 May 17;13:805966. doi: 10.3389/fphar.2022.805966. eCollection 2022. Front Pharmacol. 2022. PMID: 35656305 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
